Meanwhile, Back In the U.S.A….

Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.


Unfortunately for drug companies and bureaucrats, dumping unsafe drugs like Depo-Provera onto the Third World leads to charges of racism. To counter this impression, Dr. Malcolm Potts, the executive director of the International Fertility Research Program (an AID-funded population-control agency) suggests that Depo-Provera be approved for use here too — for the appropriate “subgroups”:

“I’d like to suggest that, even among the vast population of the United States, you can find subgroups of people who have the same problems as people in the Third World. They may not be so large, but you know you have several million immigrants from Mexico, who bring with them the same health problems, the same cultural assumptions, the same need for fertility regulation as they had in Mexico.

I think that if the FDA were to turn its attention to the needs of some of the subgroups within the United States, we would not be faced with the situation in which we can be accused of having a dual standard of medical practice and drug regulation around the world. If you look hard enough in the States, I think you can find the same type of population — as I say, it may not be very large — as one finds in the north of Thailand.”

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate